Loading…
Synthesis, analgesic, anti-inflammatory, COX/5-LOX inhibition, ulcerogenic evaluation, and docking study of benzimidazole bearing indole and benzophenone analogs
•Synthesis of benzimidazole analogs bearing benzophenone and indole moieties 10a-j.•Screening of synthesized compounds for in vivo analgesic, anti-inflammatory, and ulcerogenic evaluation.•In vitro analysis of COX-1, COX-2, and 5-LOX inhibition.•Molecular docking studies supported the investigation...
Saved in:
Published in: | Journal of molecular structure 2022-07, Vol.1259, p.132741, Article 132741 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c312t-aa0cb86a1ace6e3d92ca098697abd210878846d31f02a15c198f16bdab4ab5933 |
---|---|
cites | cdi_FETCH-LOGICAL-c312t-aa0cb86a1ace6e3d92ca098697abd210878846d31f02a15c198f16bdab4ab5933 |
container_end_page | |
container_issue | |
container_start_page | 132741 |
container_title | Journal of molecular structure |
container_volume | 1259 |
creator | Nagesh, Khadri M.J. Prashanth, T. Khamees, Hussien Ahmed Khanum, Shaukath Ara |
description | •Synthesis of benzimidazole analogs bearing benzophenone and indole moieties 10a-j.•Screening of synthesized compounds for in vivo analgesic, anti-inflammatory, and ulcerogenic evaluation.•In vitro analysis of COX-1, COX-2, and 5-LOX inhibition.•Molecular docking studies supported the investigation of the ligand binding to their target protein.•Viable dual inhibition of COX/5-LOX by the synthetic analogs.
Inflammation therapy is particularly focused on the development of safer non-steroidal anti-inflammatory drugs (NSAIDs), administered to control inflammation. It is typically considered that dual-inhibition of COX/5-LOX, which improves efficacy and has fewer side effects, is an effective technique for combating inflammation. In this perspective, the series of titled compounds (10a-j) were designed, synthesized, and characterized following with the anti-inflammatory, analgesic, and ulcerogenic evaluation. The investigation of the potentiality of the titled compounds (10a-j) displayed a high degree of anti-inflammatory activity. The compounds displaying potential analgesic activity were identified and validated further for evaluation of analgesic, anti-inflammatory activity, and subsequent ulcerogenic evaluation. In addition, the COX-1, COX-2, and 5-LOX analyses were carried out in vitro. Among (10a-j) series, compound 10c with para substitution of fluoro group on the benzoyl ring and two chloro groups at ortho position in phenyl ring of benzophenone was observed to have good inhibitory potency. Furthermore, the in silico docking study was performed by using AutoDock tools docking software. |
doi_str_mv | 10.1016/j.molstruc.2022.132741 |
format | article |
fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1016_j_molstruc_2022_132741</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022286022004148</els_id><sourcerecordid>S0022286022004148</sourcerecordid><originalsourceid>FETCH-LOGICAL-c312t-aa0cb86a1ace6e3d92ca098697abd210878846d31f02a15c198f16bdab4ab5933</originalsourceid><addsrcrecordid>eNqFUMtOwzAQtBBIlMcvIH9AU2ynTZ0bqOIlIXEAJG7Wxt60WxIb2SlS-zf8KQmFM6ed3dkZjYaxCykmUsjicj1pQ5O6uLETJZSayFzNp_KAjaSeq0wLOT1kI9EzmdKFOGYnKa2FELIXj9jX89Z3K0yUxhw8NMse2gF2lJGvG2hb6ELcjvni6e1ylj0-vXHyK6qoo-DHfNNYjGGJnizHT2g2sL-Dd9wF-05-yVO3cVseal6h31FLDnahwX6DONDk3bAOiuEhfKzQB48_ccIynbGjGpqE57_zlL3e3rws7vsodw-L68fM5lJ1GYCwlS5AgsUCc1cqC6LURTmHyikp9FzraeFyWQsFcmZlqWtZVA6qKVSzMs9PWbH3tTGkFLE2H5FaiFsjhRmKNmvzV7QZijb7onvh1V6IfbpPwmiSJfQWHUW0nXGB_rP4BuhKjrs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synthesis, analgesic, anti-inflammatory, COX/5-LOX inhibition, ulcerogenic evaluation, and docking study of benzimidazole bearing indole and benzophenone analogs</title><source>ScienceDirect Freedom Collection</source><creator>Nagesh, Khadri M.J. ; Prashanth, T. ; Khamees, Hussien Ahmed ; Khanum, Shaukath Ara</creator><creatorcontrib>Nagesh, Khadri M.J. ; Prashanth, T. ; Khamees, Hussien Ahmed ; Khanum, Shaukath Ara</creatorcontrib><description>•Synthesis of benzimidazole analogs bearing benzophenone and indole moieties 10a-j.•Screening of synthesized compounds for in vivo analgesic, anti-inflammatory, and ulcerogenic evaluation.•In vitro analysis of COX-1, COX-2, and 5-LOX inhibition.•Molecular docking studies supported the investigation of the ligand binding to their target protein.•Viable dual inhibition of COX/5-LOX by the synthetic analogs.
Inflammation therapy is particularly focused on the development of safer non-steroidal anti-inflammatory drugs (NSAIDs), administered to control inflammation. It is typically considered that dual-inhibition of COX/5-LOX, which improves efficacy and has fewer side effects, is an effective technique for combating inflammation. In this perspective, the series of titled compounds (10a-j) were designed, synthesized, and characterized following with the anti-inflammatory, analgesic, and ulcerogenic evaluation. The investigation of the potentiality of the titled compounds (10a-j) displayed a high degree of anti-inflammatory activity. The compounds displaying potential analgesic activity were identified and validated further for evaluation of analgesic, anti-inflammatory activity, and subsequent ulcerogenic evaluation. In addition, the COX-1, COX-2, and 5-LOX analyses were carried out in vitro. Among (10a-j) series, compound 10c with para substitution of fluoro group on the benzoyl ring and two chloro groups at ortho position in phenyl ring of benzophenone was observed to have good inhibitory potency. Furthermore, the in silico docking study was performed by using AutoDock tools docking software.</description><identifier>ISSN: 0022-2860</identifier><identifier>EISSN: 1872-8014</identifier><identifier>DOI: 10.1016/j.molstruc.2022.132741</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>5-LOX inhibition ; Analgesic ; Anti-inflammatory ; COX-1/COX-2 inhibition ; Docking study ; Heterocycle ; Ulcerogenic evaluation</subject><ispartof>Journal of molecular structure, 2022-07, Vol.1259, p.132741, Article 132741</ispartof><rights>2022 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c312t-aa0cb86a1ace6e3d92ca098697abd210878846d31f02a15c198f16bdab4ab5933</citedby><cites>FETCH-LOGICAL-c312t-aa0cb86a1ace6e3d92ca098697abd210878846d31f02a15c198f16bdab4ab5933</cites><orcidid>0000-0002-7500-2823</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Nagesh, Khadri M.J.</creatorcontrib><creatorcontrib>Prashanth, T.</creatorcontrib><creatorcontrib>Khamees, Hussien Ahmed</creatorcontrib><creatorcontrib>Khanum, Shaukath Ara</creatorcontrib><title>Synthesis, analgesic, anti-inflammatory, COX/5-LOX inhibition, ulcerogenic evaluation, and docking study of benzimidazole bearing indole and benzophenone analogs</title><title>Journal of molecular structure</title><description>•Synthesis of benzimidazole analogs bearing benzophenone and indole moieties 10a-j.•Screening of synthesized compounds for in vivo analgesic, anti-inflammatory, and ulcerogenic evaluation.•In vitro analysis of COX-1, COX-2, and 5-LOX inhibition.•Molecular docking studies supported the investigation of the ligand binding to their target protein.•Viable dual inhibition of COX/5-LOX by the synthetic analogs.
Inflammation therapy is particularly focused on the development of safer non-steroidal anti-inflammatory drugs (NSAIDs), administered to control inflammation. It is typically considered that dual-inhibition of COX/5-LOX, which improves efficacy and has fewer side effects, is an effective technique for combating inflammation. In this perspective, the series of titled compounds (10a-j) were designed, synthesized, and characterized following with the anti-inflammatory, analgesic, and ulcerogenic evaluation. The investigation of the potentiality of the titled compounds (10a-j) displayed a high degree of anti-inflammatory activity. The compounds displaying potential analgesic activity were identified and validated further for evaluation of analgesic, anti-inflammatory activity, and subsequent ulcerogenic evaluation. In addition, the COX-1, COX-2, and 5-LOX analyses were carried out in vitro. Among (10a-j) series, compound 10c with para substitution of fluoro group on the benzoyl ring and two chloro groups at ortho position in phenyl ring of benzophenone was observed to have good inhibitory potency. Furthermore, the in silico docking study was performed by using AutoDock tools docking software.</description><subject>5-LOX inhibition</subject><subject>Analgesic</subject><subject>Anti-inflammatory</subject><subject>COX-1/COX-2 inhibition</subject><subject>Docking study</subject><subject>Heterocycle</subject><subject>Ulcerogenic evaluation</subject><issn>0022-2860</issn><issn>1872-8014</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFUMtOwzAQtBBIlMcvIH9AU2ynTZ0bqOIlIXEAJG7Wxt60WxIb2SlS-zf8KQmFM6ed3dkZjYaxCykmUsjicj1pQ5O6uLETJZSayFzNp_KAjaSeq0wLOT1kI9EzmdKFOGYnKa2FELIXj9jX89Z3K0yUxhw8NMse2gF2lJGvG2hb6ELcjvni6e1ylj0-vXHyK6qoo-DHfNNYjGGJnizHT2g2sL-Dd9wF-05-yVO3cVseal6h31FLDnahwX6DONDk3bAOiuEhfKzQB48_ccIynbGjGpqE57_zlL3e3rws7vsodw-L68fM5lJ1GYCwlS5AgsUCc1cqC6LURTmHyikp9FzraeFyWQsFcmZlqWtZVA6qKVSzMs9PWbH3tTGkFLE2H5FaiFsjhRmKNmvzV7QZijb7onvh1V6IfbpPwmiSJfQWHUW0nXGB_rP4BuhKjrs</recordid><startdate>20220705</startdate><enddate>20220705</enddate><creator>Nagesh, Khadri M.J.</creator><creator>Prashanth, T.</creator><creator>Khamees, Hussien Ahmed</creator><creator>Khanum, Shaukath Ara</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-7500-2823</orcidid></search><sort><creationdate>20220705</creationdate><title>Synthesis, analgesic, anti-inflammatory, COX/5-LOX inhibition, ulcerogenic evaluation, and docking study of benzimidazole bearing indole and benzophenone analogs</title><author>Nagesh, Khadri M.J. ; Prashanth, T. ; Khamees, Hussien Ahmed ; Khanum, Shaukath Ara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c312t-aa0cb86a1ace6e3d92ca098697abd210878846d31f02a15c198f16bdab4ab5933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>5-LOX inhibition</topic><topic>Analgesic</topic><topic>Anti-inflammatory</topic><topic>COX-1/COX-2 inhibition</topic><topic>Docking study</topic><topic>Heterocycle</topic><topic>Ulcerogenic evaluation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nagesh, Khadri M.J.</creatorcontrib><creatorcontrib>Prashanth, T.</creatorcontrib><creatorcontrib>Khamees, Hussien Ahmed</creatorcontrib><creatorcontrib>Khanum, Shaukath Ara</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of molecular structure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nagesh, Khadri M.J.</au><au>Prashanth, T.</au><au>Khamees, Hussien Ahmed</au><au>Khanum, Shaukath Ara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis, analgesic, anti-inflammatory, COX/5-LOX inhibition, ulcerogenic evaluation, and docking study of benzimidazole bearing indole and benzophenone analogs</atitle><jtitle>Journal of molecular structure</jtitle><date>2022-07-05</date><risdate>2022</risdate><volume>1259</volume><spage>132741</spage><pages>132741-</pages><artnum>132741</artnum><issn>0022-2860</issn><eissn>1872-8014</eissn><abstract>•Synthesis of benzimidazole analogs bearing benzophenone and indole moieties 10a-j.•Screening of synthesized compounds for in vivo analgesic, anti-inflammatory, and ulcerogenic evaluation.•In vitro analysis of COX-1, COX-2, and 5-LOX inhibition.•Molecular docking studies supported the investigation of the ligand binding to their target protein.•Viable dual inhibition of COX/5-LOX by the synthetic analogs.
Inflammation therapy is particularly focused on the development of safer non-steroidal anti-inflammatory drugs (NSAIDs), administered to control inflammation. It is typically considered that dual-inhibition of COX/5-LOX, which improves efficacy and has fewer side effects, is an effective technique for combating inflammation. In this perspective, the series of titled compounds (10a-j) were designed, synthesized, and characterized following with the anti-inflammatory, analgesic, and ulcerogenic evaluation. The investigation of the potentiality of the titled compounds (10a-j) displayed a high degree of anti-inflammatory activity. The compounds displaying potential analgesic activity were identified and validated further for evaluation of analgesic, anti-inflammatory activity, and subsequent ulcerogenic evaluation. In addition, the COX-1, COX-2, and 5-LOX analyses were carried out in vitro. Among (10a-j) series, compound 10c with para substitution of fluoro group on the benzoyl ring and two chloro groups at ortho position in phenyl ring of benzophenone was observed to have good inhibitory potency. Furthermore, the in silico docking study was performed by using AutoDock tools docking software.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.molstruc.2022.132741</doi><orcidid>https://orcid.org/0000-0002-7500-2823</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2860 |
ispartof | Journal of molecular structure, 2022-07, Vol.1259, p.132741, Article 132741 |
issn | 0022-2860 1872-8014 |
language | eng |
recordid | cdi_crossref_primary_10_1016_j_molstruc_2022_132741 |
source | ScienceDirect Freedom Collection |
subjects | 5-LOX inhibition Analgesic Anti-inflammatory COX-1/COX-2 inhibition Docking study Heterocycle Ulcerogenic evaluation |
title | Synthesis, analgesic, anti-inflammatory, COX/5-LOX inhibition, ulcerogenic evaluation, and docking study of benzimidazole bearing indole and benzophenone analogs |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T16%3A00%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis,%20analgesic,%20anti-inflammatory,%20COX/5-LOX%20inhibition,%20ulcerogenic%20evaluation,%20and%20docking%20study%20of%20benzimidazole%20bearing%20indole%20and%20benzophenone%20analogs&rft.jtitle=Journal%20of%20molecular%20structure&rft.au=Nagesh,%20Khadri%20M.J.&rft.date=2022-07-05&rft.volume=1259&rft.spage=132741&rft.pages=132741-&rft.artnum=132741&rft.issn=0022-2860&rft.eissn=1872-8014&rft_id=info:doi/10.1016/j.molstruc.2022.132741&rft_dat=%3Celsevier_cross%3ES0022286022004148%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c312t-aa0cb86a1ace6e3d92ca098697abd210878846d31f02a15c198f16bdab4ab5933%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |